Vaccine News: Brazil Suspends Clinical Trials Of Chinese COVID-19 Vaccine Called Coronavac made By Sinovac Biotech
Source: Vaccine News Nov 10, 2020 4 years, 1 week, 4 days, 4 hours, 32 minutes ago
Vaccine News: Another latest development in the trillion dollar COVID-19 vaccine sector that is plagued with scams, lies, cover-ups and greed as Brazil announces a sudden suspension of all clinical trials involving the Chinese COVID-19 vaccine called Coronavac made by Sinovac Biotech.
.jpg)
24 hours ago, Brazil's health regulator said it had suspended clinical trials of a Chinese-developed COVID-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.
The sudden setback for CoronaVac, came on Monday as US pharmaceutical giant Pfizer said its own vaccine candidate had shown 90 percent effectiveness sending global markets soaring and raising hopes of an end to the pandemic despite having no supporting data or published studies to back its claims.
https://www.thailandmedical.news/news/covid-19-vaccine-more-american-scams-pfizer-announces-preliminary-results-that-suggested-their-vaccine-was-more-than-90-percent-effective
The China based company where the SARS-CoV -2 coronavirus first appeared on Tuesday stood by its creation, saying: "We are confident in the safety of the vaccine".
Anvisa, the Brazilian regulator said it had "ruled to interrupt the clinical study of the CoronaVac vaccine after a serious adverse incident" involving a volunteer recipient on October 29.
The regulator it said it could not give details on what happened because of privacy regulations, but that such incidents included death, potentially fatal side effects, serious disability, hospitalization, birth defects and other "clinically significant events."
The Chines biotech company, Sinovac, however, said the incident was "not related to the vaccine", adding it will "continue to communicate with Brazil on this matter."
The controversial the public health center coordinating the trials of the vaccine in Brazil, the Butantan Institute, said it was "surprised" by Anvisa's decision. (The same institute is facing allegations of corruption.)
The Butantan Institute "is investigating in detail what happened," and "is at the Brazilian regulatory agency's disposal to provide any clarification necessary on any adverse incident the clinical trials may have presented.”
The Chinese COVID-19 vaccine has been caught up in a messy political battle in Brazil, where its most visible backer has been Sao Paulo Governor Joao Doria, a top opponent of far-right President Jair Bolsonaro.
Interestingly The Sao Paulo state government said in a statement it "regrets that it learned of the decision from the press, instead of directly from Anvisa," and was waiting along with the Butantan Institute for more information on "the real reasons for the suspension."
President Bolsonaro has labeled CoronaVac the vaccine from "that other country," and pushed in
stead for a rival vaccine developed by Oxford University and pharmaceutical firm AstraZeneca.
In October , he shot down a plan by his own health minister to buy 46 million doses of CoronaVac, saying, "The Brazilian people will not be anyone's guinea pig," and referring to it as "Joao Doria's Chinese vaccine."
Sao Paulo Governor Joao Doria announced earlier Monday that the first 120,000 doses of CoronaVac would arrive in Sao Paulo on November 20.
Sao Paulo has a deal with Sinovac to buy a total of 46 million doses ie six million produced in China and the rest produced in Sao Paulo, which broke ground last week on a factory to make the vaccine domestically.
Health officials in the state government fear Bolsonaro will use technical decisions to delay the timeline of the vaccine for political reasons.
The regulator Anvisa told media it had no comment beyond its statement announcing the suspension, which said that halting trials was standard procedure in such cases.
President Bolsonaro faces criticism for his handling of the pandemic, which has included playing down the virus, opposing lockdown measures and relentlessly promoting the drug hydroxychloroquine despite studies showing it is ineffective against COVID-19.
The three controversial vaccines ie Sinovac, Pfizer and Oxford vaccines are all in Phase 3 trials, the final stage of testing before regulatory approval.
Interestingly all are being tested in Brazil, the country with the second-highest death toll in the pandemic after the United States, with more than 162,000 people killed by the new coronavirus.
Also of interest is the fact that the Chinese vaccine which some orthodox Muslims have termed as ‘non-halal vaccines’ are being tested in certain Muslim countries in the Middle-East with some Muslim rulers swearing by the efficacy of these ‘non-halal vaccines’! Even another Chinese company Sinopharm is having its non-halal vaccines tested in the muslim Middle-East countries.
https://www.thailandmedical.news/news/breaking-covid-19-vaccine-as-chinese-vaccine-developer-sinopharm-starts-phase-3-trial-in-abu-dhabi,-angry-devout-muslims-are-asking-how-halal-are-thes
For
Vaccine News, keep on logging to Thailand Medical News.
